Daniela Drago

Dr. Drago is a Partner with NDA Partners and has worked with the company since 2022. She is a regulatory affairs executive with a history of accomplishments spanning pharmaceutical, biotech, and academic roles. She has significant global expertise in the development of small molecules, biologics, cell and gene therapies, and combination products in multiple rare and common disease areas, including ophthalmology, neurology, immunology, and oncology.